Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 6.13 GBp
Change Today 0.00 / 0.00%
Volume 306.4K
As of 11:30 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

deltex medical group plc (DEMG) Snapshot

6.13 GBp
Previous Close
6.13 GBp
Day High
6.13 GBp
Day Low
6.13 GBp
52 Week High
07/15/14 - 10.75 GBp
52 Week Low
02/19/15 - 3.38 GBp
Market Cap
Average Volume 10 Days
-0.01 GBp
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

deltex medical group plc (DEMG) Related Businessweek News

No Related Businessweek News Found

deltex medical group plc (DEMG) Details

Deltex Medical Group plc, together with its subsidiaries, manufactures and markets oesophageal doppler monitoring (ODM) systems in the United Kingdom, the United States, Spain, Canada, and internationally. The company offers CardioQ-ODM that allows clinicians to guide fluid and drug administration during surgery and critical care; CardioQ-ODM+, a fluid management and cardiac output monitoring system to measure flow and pressure directly; oesophageal doppler probes; USCOM 1A monitor, a noninvasive device for high resolution measurement of the circulation; and FORE-SIGHT Absolute Tissue Oximetry that allows clinicians to treat cerebral desaturation events. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom.

106 Employees
Last Reported Date: 03/11/15
Founded in 2000

deltex medical group plc (DEMG) Top Compensated Officers

Chief Executive Officer and Executive Directo...
Total Annual Compensation: 200.0K GBP
Finance Director
Total Annual Compensation: 125.0K GBP
Compensation as of Fiscal Year 2014.

deltex medical group plc (DEMG) Key Developments

Jonathan Shaw to Join the Deltex Medical Group plc as Group Finance Director with Effect from September 1, 2015

Deltex Medical Group plc announced that it has appointed Jonathan Shaw to join the board as group finance director with effect from 1 September 2015. Jonathan David Shaw is a Chartered Certified Accountant (FCCA). Mr. Shaw has spent the majority of his career working at either director or senior manager level in professional accounting and auditing firms most recently with Grant Thornton UK LLP in London and including PricewaterhouseCoopers LLP in Southampton where he was Deltex Medical's senior audit manager for nearly four years. During his career Mr. Shaw has undertaken a number of secondments to industry or government and spent almost three years at the Financial Reporting Council, the UK's independent regulator responsible for promoting high quality corporate governance and reporting to foster investment, as a case officer at the Financial Reporting Review Panel. Mr. Shaw is a member of the Association of Chartered Certified Accountant's Global Corporate Reporting Forum and a specialist business mentor for The Prince's Trust.

Deltex Medical Group plc Appoints Christopher Jones as a Non-Executive Director

Deltex Medical Group plc announced that, further to the announcement on 24 April 2015, Mr. Christopher Jones has been appointed to the Board as a Non-Executive Director with effect from 1 June 2015. Mr. Jones has almost 25 years' of experience in the healthcare industry, both in the UK and importantly throughout the USA. He brings valuable experience to Deltex which will be of great assistance to the Company as it seeks to capitalise on its leading position in ODM in the USA. Mr. Jones worked in marketing leadership roles in the USA for Tyco Healthcare (now Covidien Inc) for nine years until 2004 and subsequently as Vice President of Marketing for the Nellcor monitoring and critical care division. Recently he was CEO of Tensys Medical Inc. until a successful sale of the business. From 2008 until April 2015 he was CEO of Glysure Limited.

Deltex Medical Group to Appoint Chris Jones as a Non-Executive Director

Deltex Medical Group plc announced that it intends to appoint Chris Jones as a Non-Executive Director after the company's Annual General Meeting to be held on 6 May 2015. Christopher Michael Jones, aged 48, is a US citizen with over 25 years' experience in the medical technology industry in senior management positions for both large multi-national and smaller early stage companies.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DEMG:LN 6.13 GBp 0.00

DEMG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Edwards Lifesciences Corp $142.45 USD -1.15
LiDCO Group PLC 10.88 GBp 0.00
Masimo Corp $38.61 USD -0.16
Pulsion Medical Systems SE €24.30 EUR 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation DEMG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.0x
Price/Book 2.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DELTEX MEDICAL GROUP PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at